HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 323 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $79,426 | -15.2% | 2,202 | -10.2% | 0.00% | 0.0% |
Q1 2023 | $93,680 | -84.5% | 2,453 | -77.0% | 0.00% | -86.2% |
Q4 2022 | $605,644 | +49.2% | 10,644 | +3.7% | 0.03% | +20.8% |
Q3 2022 | $406,000 | -32.4% | 10,262 | -24.8% | 0.02% | -14.3% |
Q2 2022 | $601,000 | +144.3% | 13,648 | +121.5% | 0.03% | +180.0% |
Q1 2022 | $246,000 | -50.1% | 6,162 | -49.7% | 0.01% | -44.4% |
Q4 2021 | $493,000 | -29.2% | 12,259 | -28.4% | 0.02% | -18.2% |
Q3 2021 | $696,000 | -17.7% | 17,113 | -8.1% | 0.02% | +10.0% |
Q2 2021 | $846,000 | -48.1% | 18,629 | -52.3% | 0.02% | -48.7% |
Q1 2021 | $1,629,000 | +11.0% | 39,066 | +13.7% | 0.04% | +25.8% |
Q4 2020 | $1,468,000 | +118.8% | 34,364 | +34.7% | 0.03% | +106.7% |
Q3 2020 | $671,000 | -33.4% | 25,518 | -32.0% | 0.02% | -31.8% |
Q2 2020 | $1,007,000 | +36.8% | 37,551 | -8.2% | 0.02% | +22.2% |
Q1 2020 | $736,000 | +1.5% | 40,904 | 0.0% | 0.02% | +12.5% |
Q4 2019 | $725,000 | -25.9% | 40,904 | -15.3% | 0.02% | -27.3% |
Q4 2017 | $978,000 | +16.7% | 48,270 | 0.0% | 0.02% | +15.8% |
Q3 2017 | $838,000 | +233.9% | 48,270 | +147.0% | 0.02% | +216.7% |
Q2 2017 | $251,000 | -0.8% | 19,543 | 0.0% | 0.01% | 0.0% |
Q1 2017 | $253,000 | -43.5% | 19,543 | -56.9% | 0.01% | -40.0% |
Q4 2016 | $448,000 | – | 45,331 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |